# Pharmacokinetics and Safety of BI 695501

> **NCT02899338** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 162 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI695501 Prefilled syringe
- **DRUG:** BI695501Autoinjector

## Key facts

- **NCT ID:** NCT02899338
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-21
- **Primary completion:** 2017-02-09
- **Final completion:** 2017-02-23
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899338, "Pharmacokinetics and Safety of BI 695501". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02899338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*